PMID: 3772372Dec 1, 1986Paper

alpha-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain

Journal of Neurochemistry
S Wonnacott

Abstract

Reported differences in the pharmacology and distribution of [3H]nicotine and [125I]alpha-bungarotoxin binding sites in mammalian brain suggest that these ligands label separate receptor sites. Affinity purification of an alpha-bungarotoxin binding protein from rat brain failed to copurify the high-affinity nicotine binding site, which remained in the nonbound soluble fraction after the affinity chromatography step. This confirms the independence of these putative receptor sites. Nevertheless, the binding of [125I]alpha-bungarotoxin to P2 membranes was inhibited by (-)-nicotine (Ki = 9 X 10(-6) M), and this sensitivity was preserved after affinity purification. It is proposed that alpha-bungarotoxin binds to a population of low-affinity nicotine binding sites. Comparison of the enantiomers of nicotine in competition studies at both radioligand binding sites revealed an 80-fold preference for the (-) form at the high-affinity [3H]nicotine binding site, whereas the site labelled by [125I]alpha-bungarotoxin displayed little stereoselectivity. In this respect, the brain alpha-bungarotoxin binding site resembles the nicotinic acetylcholine receptor from Torpedo electric organ.

References

Feb 1, 1979·Journal of Medicinal Chemistry·M D AcetoW C Vincek
Jun 1, 1985·The Journal of Pharmacy and Pharmacology·M E Benwell, J K Balfour
Jan 1, 1986·Psychopharmacology·I P StolermanI C Rose
Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·B M Conti-TronconiM A Raftery
Jan 21, 1985·Neuroscience Letters·E D LondonJ K Wamsley
Apr 1, 1973·Analytical Biochemistry·J Schmidt, M A Raftery
Dec 10, 1984·Brain Research·P B ClarkeA Pert
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R I NormanJ O Dolly
Mar 15, 1984·Biochemical Pharmacology·J O Dolly, E A Barnard
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·J W SloanW R Martin
May 1, 1984·Journal of Neurochemistry·E HayashiS Yamada
Oct 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·K YoshidaS Liljequist
Mar 16, 1981·European Journal of Biochemistry·F A StephensonG G Lunt
Jan 1, 1981·Journal of Receptor Research·H SershenJ Gennaro
Jan 1, 1981·Methods in Enzymology·J LindstromS Tzartos
Nov 7, 1980·Science·C Romano, A Goldstein
Jan 1, 1985·Neurochemistry International·C RapierS Wonnacott
Jan 1, 1985·Neurochemistry International·J WhyteS Wonnacott

❮ Previous
Next ❯

Citations

Aug 1, 1996·European Journal of Nuclear Medicine·F GrünwaldW Kuschinsky
Jan 1, 1988·Molecular Neurobiology·K Miles, R L Huganir
Jan 1, 1987·Molecular Neurobiology·J LindstromP Whiting
Aug 15, 2009·Journal of Molecular Neuroscience : MN·Sharon MexalSherry Leonard
Dec 1, 1991·Pharmacology & Therapeutics·J A Court, E K Perry
Aug 21, 1992·Brain Research. Developmental Brain Research·B NaeffW Lichtensteiger
Aug 27, 2013·Neurobiology of Learning and Memory·Thomas J Gould, Prescott T Leach
Apr 20, 2000·European Journal of Pharmacology·S LeonardR Freedman
Oct 9, 1999·Pharmacology, Biochemistry, and Behavior·F van HaarenW R Kem
Jul 29, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yantao ZuoElliot A Stein
Jan 1, 1989·Critical Reviews in Biochemistry and Molecular Biology·R L Huganir, K Miles
Jun 1, 1991·Journal of Neurochemistry·R V BhatA C Collins
Mar 1, 1988·Journal of Neurochemistry·J A StitzelM J Marks
Aug 2, 2015·Biochemical Pharmacology·Munir Gunes Kutlu, Thomas J Gould
Sep 1, 1987·Human Toxicology·S Wonnacott
Dec 13, 1988·Brain Research·N J Cairns, S Wonnacott
Jul 25, 2021·Pharmacological Reviews·Roger L Papke, Nicole A Horenstein
Aug 1, 1988·Pharmacological Research Communications·C GottiF Clementi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.